# Clinical Study of AFN50 Injection in the Autoimmune Diseases

> **NCT07408336** · EARLY_PHASE1 · RECRUITING · sponsor: **AlphaNa Bioscience Company Limited** · enrollment: 18 (estimated)

## Conditions studied

- Autoimmune Diseases

## Interventions

- **BIOLOGICAL:** AFN50 injection

## Key facts

- **NCT ID:** NCT07408336
- **Lead sponsor:** AlphaNa Bioscience Company Limited
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-04
- **Primary completion:** 2028-02-04
- **Final completion:** 2029-02-03
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07408336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07408336, "Clinical Study of AFN50 Injection in the Autoimmune Diseases". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07408336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*